Sodium butyrate supresses malignant human mast cell proliferation, downregulates expression of KIT and promotes differentiation
Sodium butyrate (NaBu) is a class I histone deacetylase inhibitor (HDACi) that can impede the proliferation of transformed cells. Although some HDACi downregulate the expression of the stem cell factor receptor (KIT/CD117), the effect of NaBu on KIT expression and human mast cell proliferation requi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Allergy |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/falgy.2023.1109717/full |